Goldman units log Attovia (NASDAQ: ATTO) 500K-share buy and equity swap trades
Rhea-AI Filing Summary
Attovia Therapeutics, Inc. (ATTO) reported insider activity by multiple Goldman Sachs–affiliated entities, all listed as former 10% owners. On August 6, 2026, they reported the conversion of Series B and Series C Preferred Stock into common stock, eliminating 18,181,830 Series B and 4,445,275 Series C preferred shares and issuing 1,957,134 and 478,598 common shares, respectively. This corrects an administrative error in an earlier Form 3 and reflects automatic conversion upon the IPO after a 1‑for‑9.29 reverse stock split.
On the same date, an affiliated entity purchased 500,000 common shares at $17.00 per share. On August 5, 2026, Goldman Sachs & Co. LLC, acting as a market maker, purchased 85,000 shares, sold 105,807 shares, and entered into long equity swap positions referencing 105,807 shares at prices around $21.22–$21.27. The reporting persons disclaim beneficial ownership except to the extent of any pecuniary interest, and any Section 16(b) profit from the market‑making trades will be remitted to Attovia.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series B Preferred Stock F4, F5, F3, F6, F7 | 18,181,830 | $0.00 | $0.00 |
| Conversion | Series C Preferred Stock F4, F5, F3, F6, F7 | 4,445,275 | $0.00 | $0.00 |
| Conversion | Common Stock F4, F5, F3, F6, F7 | 1,957,134 | $0.00 | $0.00 |
| Conversion | Common Stock F4, F5, F3, F6, F7 | 478,498 | $0.00 | $0.00 |
| Purchase | Common Stock F4, F1, F2 | 500,000 | $17.00 | $8.50M |
| Purchase | Equity Swap F3, F1, F2 | 2,872 | $21.22 | $61K |
| Purchase | Equity Swap F3, F1, F2 | 28,717 | $21.22 | $609K |
| Purchase | Equity Swap F3, F1, F2 | 11,488 | $21.22 | $244K |
| Purchase | Equity Swap F3, F1, F2 | 45,588 | $21.27 | $970K |
| Purchase | Equity Swap F3, F1, F2 | 11,398 | $21.27 | $242K |
| Purchase | Equity Swap F3, F1, F2 | 5,744 | $21.22 | $122K |
| Purchase | Common Stock F1, F2 | 85,000 | $21.00 | $1.78M |
| Sale | Common Stock F1, F2, F3 | 988 | $22.03 | $22K |
| Sale | Common Stock F1, F2, F3 | 447 | $21.87 | $10K |
| Sale | Common Stock F1, F2, F3 | 1,332 | $22.03 | $29K |
| Sale | Common Stock F1, F2, F3 | 200 | $22.05 | $4K |
| Sale | Common Stock F1, F2, F3 | 1,556 | $22.06 | $34K |
| Sale | Common Stock F1, F2, F3 | 3,402 | $22.02 | $75K |
| Sale | Common Stock F1, F2, F3 | 200 | $22.10 | $4K |
| Sale | Common Stock F1, F2, F3 | 480 | $21.55 | $10K |
| Sale | Common Stock F1, F2, F3 | 100 | $22.11 | $2K |
| Sale | Common Stock F1, F2, F3 | 753 | $21.97 | $17K |
| Sale | Common Stock F1, F2, F3 | 672 | $22.02 | $15K |
| Sale | Common Stock F1, F2, F3 | 6,970 | $22.03 | $154K |
| Sale | Common Stock F1, F2, F3 | 400 | $22.02 | $9K |
| Sale | Common Stock F1, F2, F3 | 1,180 | $21.84 | $26K |
| Sale | Common Stock F1, F2, F3 | 1,040 | $22.05 | $23K |
| Sale | Common Stock F1, F2, F3 | 300 | $20.84 | $6K |
| Sale | Common Stock F1, F2, F3 | 443 | $21.78 | $10K |
| Sale | Common Stock F1, F2, F3 | 200 | $22.05 | $4K |
| Sale | Common Stock F1, F2, F3 | 700 | $22.07 | $15K |
| Sale | Common Stock F1, F2, F3 | 1,163 | $22.19 | $26K |
| Sale | Common Stock F1, F2, F3 | 100 | $21.99 | $2K |
| Sale | Common Stock F1, F2, F3 | 6,763 | $21.61 | $146K |
| Sale | Common Stock F1, F2, F3 | 76,418 | $21.04 | $1.61M |
Footnotes (7)
- F1. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.
- F2. These transactions in or with respect to the common stock of the Issuer were effected by Goldman Sachs & Co. LLC ("GS&Co") acting as a market maker in the ordinary course of business. Without conceding market making trades in the ordinary course of business can result in liability under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that they were subject to Section 16(b) will be remitted to the Issuer.
- F3. GS&Co's transactions in or with respect to the Issuer's common stock on August 5, 2026 consisted of purchases of a total of 85,000 shares, sales of a total of 105,807 shares, and establishment of long equity swap positions with respect to a total of 105,807 shares. The equity swap positions were inadvertently omitted from the Reporting Persons' original Form 4.
- F4. The previous report on Form 3 reflected an administrative error with respect to the number of shares of common stock issuable upon conversion of the Preferred Stock, which is corrected in this Form 4.
- F5. All shares of the Issuer's redeemable convertible preferred stock automatically converted into shares of the Issuer's common stock on a 1-for-1 basis, adjusted for a 1-for-9.29 reverse stock split effected by the Issuer on July 29, 2026, upon the completion of the Issuer's initial public offering (the "IPO").
- F6. This statement is being filed by Goldman Sachs Group, Inc. ("GS Group"), GS&Co, Goldman Sachs Asset Management, L.P. ("GSAM LP"), Broad Street Principal Investments L.L.C. ("BSPI"), which directly holds 96,190 shares of common stock purchased in the IPO and 468,565 shares of common stock converted from 3,497,806 shares of Series B Preferred Stock and 855,179 shares of Series C Preferred Stock, WSLS Offshore Investments, SLP ("WSLS Offshore"), which directly holds 131,283 shares of common stock purchased in the IPO and 639,518 shares of common stock converted from 4,773,948 shares of Series B Preferred Stock and 1,167,182 shares of Series C Preferred Stock, West Street Life Sciences I, L.P. ("WSLS I"), which directly holds 137,708 shares of common stock purchased in the IPO and 670,812 shares of common stock converted from 5,007,564 shares of Series B Preferred Stock and 1,224,299 shares of Series C Preferred Stock,... (continued in footnote 7)
- F7. (continued from footnote 6)...WSLS Emp Offshore Investments, L.P. ("WSLS Emp Offshore"), which directly holds 36,927 shares of common stock purchased in the IPO and 179,879 shares of common stock converted from 1,342,794 shares of Series B Preferred Stock and 328,300 shares of Series C Preferred Stock, and WSLS Emp Onshore Investments, L.P. ("WSLS Emp Onshore"), which directly holds 97,892 shares of common stock purchased in the IPO and 476,858 shares of common stock converted from 3,559,718 shares of Series B Preferred Stock and 870,315 shares of Series C Preferred Stock. GS&Co is a direct subsidiary of GS Group and is the manager of BSPI. WSLS Offshore, WSLS I, WSLS Emp Offshore, and WSLS Emp Onshore are investment vehicles managed by GSAM LP, an indirect subsidiary of GS Group.
Key Figures
Key Terms
market maker financial
equity swap financial
reverse stock split financial
redeemable convertible preferred stock financial
initial public offering financial
pecuniary interest financial
FAQ
What equity swap positions referencing ATTO stock were disclosed?
How does the filing describe Goldman Sachs’ beneficial ownership of ATTO securities?
What correction to prior ATTO reporting is noted in this Form 4/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.